Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Katelyn M. Atkins(Cedars-Sinai Medical Center), Raymond H. Mak(Twitter (United States)), Paul L. Nguyen(Beth Israel Deaconess Medical Center), Nayan Lamba(Harvard University), Udo Hoffmann(Duke Medical Center), Danielle S. Bitterman(Brigham and Women's Hospital), Aileen B. Chen(Dana-Farber Cancer Institute), Tafadzwa L. Chaunzwa(Howard Hughes Medical Institute), Bhupendra Rawal(Harvard University), Anthony V. D’Amico(Brigham and Women's Hospital), David Kozono(Brigham and Women's Hospital), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Hugo J.W.L. Aerts(Harvard University), Christopher L. Williams(Dana-Farber Cancer Institute), Anju Nohria(Brigham and Women's Hospital)
Cited by 270
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
|Circulation|2020|535
Arterial Inflammation in Patients With HIV
|JAMA|2012|460